Company Description

H. Lundbeck A/S was founded in 1915 and is today an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. Key focus areas in H. Lundbeck A/S are depression, schizophrenia, Alzheimers, Parkinsons and sleep disorders, which all have their foundation in the Central Nervous System. H. Lundbeck A/S believes improving the quality of life of patients is best achieved through investment in knowledge, research, education and a holistic attitude to patient care. H. Lundbeck A/S' vision is to become a world leader in psychiatry and neurology.